GLOW Peptide BlendAlso known as: GHK-Cu, BPC-157, TB-500, Thymosin Beta-4 fragment

Mechanism of Action

The GLOW blend combines three peptides each with distinct but complementary mechanisms. GHK-Cu is a copper-binding tripeptide that influences gene expression related to collagen synthesis, extracellular matrix remodeling, and wound healing by promoting decorin and fibronectin production and modulating matrix metalloproteinase activity. BPC-157 is a pentadecapeptide derived from human gastric juice protein that promotes angiogenesis, tendon and ligament healing, and gastrointestinal protection, likely through growth factor modulation and inflammatory signaling pathways. TB-500 is a synthetic fragment of thymosin beta-4 that promotes actin polymerization by sequestering G-actin monomers, thus enhancing cellular migration, angiogenesis, and tissue structural organization. Combined in a 50mg (GHK-Cu)/10mg (BPC-157)/10mg (TB-500) ratio, these peptides synergistically support tissue remodeling, cellular repair, and inflammatory pathway modulation.

Reported Research Benefits

Research applications include tissue regeneration studies, wound healing models, cellular repair mechanisms, inflammation modulation, extracellular matrix regulation, angiogenesis, tendon and ligament healing, and structural tissue recovery.

Dosing Protocol & Reconstitution

Available as a lyophilized powder in a 3mL sealed glass vial with composition 50mg GHK-Cu, 10mg BPC-157, and 10mg TB-500. Typical research dosing depends on model system; individual peptides have been studied in rodent models using doses ranging from micrograms to milligrams. Exact dosing protocols should be adjusted based on experimental design.

Research Notes

GHK-Cu studies document enhanced collagen and glycosaminoglycan production, activation of tissue remodeling genes, and modulation of matrix metalloproteinases. BPC-157 research reports accelerated healing in tendon transection, muscle crush injuries, and gastrointestinal injuries in rodent models. TB-500 promotes actin filament formation, cell migration, and angiogenesis with demonstrated efficacy in endothelial and corneal wound healing animal studies. The blend is Janoshik-verified for identity, potency, and purity.

Research Summary

A cosmetically-focused peptide blend targeting skin health and radiance. Typically combines skin-active peptides such as GHK-Cu (collagen stimulation), Epithalon (anti-aging, telomerase activation), and BPC-157 or similar healing peptides to promote dermal regeneration, reduce oxidative damage, and improve skin texture and elasticity.

Side Effects & Safety

Dependent on individual components. Generally well-tolerated for skin-focused applications. Injection site reactions possible. GHK-Cu component is among the best-studied cosmetic peptides with an excellent safety record.

Stability & Storage

Refer to research notes

Molecular Data

Sequence: GHK-Cu: Gly-His-Lys-Cu complex, BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, TB-500: (fragment of Thymosin Beta-4, exact sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Glu-Glu-Gln-Val-Ser-Glu-Glu-Phe-Ser-Asp-Leu-Thr-Glu-Lys-Thr-Phe-Thr-Glu-Asp-Lys-Ser-Asn-Lys)
Molecular Formula: GHK-Cu: C14H22CuN6O4, BPC-157: C62H98N16O22, TB-500: C212H350N56O78S
Molecular Weight: 6723.8 g/mol
CAS Number: GHK-Cu: 89030-95-5, BPC-157: 137525-51-0, TB-500: 77591-33-4

Primary literature: https://pubmed.ncbi.nlm.nih.gov/?term=GHK-Cu+skin+collagen+aging+peptide